Elanix Biotechnologies AG
ELN | F
Overview
Corporate Details
- ISIN(s):
- DE000A0WMJQ4
- LEI:
- 391200SYNFFL0NPAJK90
- Country:
- Germany
- Address:
- Hanauer Landstrasse 291, 60314 Frankfurt am Main
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2012 as a spin-off from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Epalinges, Switzerland with offices in Hamburg and listed on the Frankfurt stock exchange under the symbol ELN.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-14 10:05 |
Board/Management Information
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
|
English | 5.1 KB | ||
| 2022-12-21 18:30 |
Major Shareholding Notification
|
German | 4.6 KB | ||
| 2022-12-19 12:30 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.0 KB | ||
| 2022-12-06 13:00 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.2 KB | ||
| 2022-12-05 10:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 13.7 KB | ||
| 2022-12-02 15:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.0 KB | ||
| 2020-02-27 12:19 |
Board/Management Information
ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD …
|
English | 4.8 KB | ||
| 2019-10-03 10:34 |
Report Publication Announcement
|
English | 2.0 KB | ||
| 2019-08-21 16:49 |
Report Publication Announcement
|
English | 2.0 KB | ||
| 2019-08-19 16:58 |
Report Publication Announcement
|
English | 2.0 KB | ||
| 2019-07-26 13:51 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | ||
| 2019-07-23 16:59 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | ||
| 2019-07-22 10:17 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | ||
| 2019-06-25 14:03 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.9 KB | ||
| 2019-06-25 13:57 |
Major Shareholding Notification
|
English | 13.9 KB |
Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
